Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Cancer Tumor Profiling Global Market Report 2025
Download Free Sample Buy Now
Global Cancer Tumor Profiling Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Cancer Tumor Profiling Global Market Report 2025

By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types ), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies), By Process Type (Genomics, Proteomics, Epigenetics, Metabolomics, Other Types), By Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cancer Tumor Profiling Market Overview

• Cancer Tumor Profiling market size has reached to $13 billion in 2024

• Expected to grow to $25.12 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%

• Growth Driver: Rising Incidences Of Cancer Across Globe

• Market Trend: Increasing Research And Development Activities

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cancer Tumor Profiling Market?

Cancer tumor profiling refers to a laboratory test that examines a sample of tumor tissue for specific genes, gene mutations (changes), proteins, or other biomarkers. Tumor profiling can help with treatment planning as well as predicting if cancer will recur or spread to other parts of the body.

The main types of cancer and tumor profiling are lung cancer, breast cancer, colorectal cancer, prostate cancer, melanoma, ovarian cancer, stomach cancer, pancreatic cancer, thyroid cancer, and other cancer types. The different technologies include next-generation sequencing (NGS), polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), microarrays, and others, and involve various types of processes such as genomics, proteomics, epigenetics, metabolomics, and others. It is used in several applications, including personalized medicine, diagnostics, biomarker discovery, prognostics, and research applications.

Cancer Tumor Profiling Market Size and growth rate 2025 to 2029: Graph

What Is The Cancer Tumor Profiling Market Size 2025 And Growth Rate?

The cancer tumor profiling market size has grown rapidly in recent years. It will grow from $13.0 billion in 2024 to $14.97 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to increasing cancer incidence, growth in precision medicine initiatives and research collaborations, improved cancer diagnostics and early detection methods, availability of a wide range of targeted therapy options, and supportive regulatory frameworks for cancer profiling tests.

What Is The Cancer Tumor Profiling Market Growth Forecast?

The cancer tumor profiling market size is expected to see rapid growth in the next few years. It will grow to $25.12 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to expansion of immunotherapy and immunoprofiling in cancer treatment, development of liquid biopsy and non-invasive tumor profiling methods, adoption of single-cell sequencing for more detailed tumor characterization, expansion of cancer screening and early detection programs, and increasing demand for rare and orphan cancer subtype profiling. Major trends in the forecast period include integration of tumor profiling into routine clinical practice, advances in multi-omics approaches, integration of artificial intelligence (ai) and machine learning in data analysis, personalized medicine and targeted therapy development, and advances in genomics and next-generation sequencing (ngs) technologies.

The forecast of 13.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. precision medicine by restricting access to multi-omic profiling services and Artificial intelligence(AI)-based tumor analysis software imported from Canada and Sweden, potentially compromising personalized therapy selection. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Cancer Tumor Profiling Market Segmented?

1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies

3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types

4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

Subsegments:

1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)

2) By Breast Cancer: Hormone Receptor-Positive, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer

3) By Colorectal Cancer: Colon Cancer, Rectal Cancer

4) By Prostate Cancer: Localized Prostate Cancer, Advanced Prostate Cancer

5) By Melanoma: Cutaneous Melanoma, Non-Cutaneous Melanoma

6) By Ovarian Cancer: Epithelial Ovarian Cancer, Non-Epithelial Ovarian Cancer

7) By Stomach Cancer: Gastric Adenocarcinoma, Gastrointestinal Stromal Tumors (GISTs)

8) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Neuroendocrine Tumors

9) By Thyroid Cancer: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer

10) By Other Cancer Types: Kidney Cancer, Bladder Cancer, Liver Cancer, Esophageal Cancer

What Is Driving The Cancer Tumor Profiling Market? Rising Incidences Of Cancer Across Globe

The increasing incidences of cancer across the globe are expected to propel the growth of the cancer and tumor profiling market going forward. Cancer is a disease in which some cells in the body get uncontrollably large and spread to other parts of the body. As the number of cancer cases rises, so does the demand for cancer tumor profiling, which enables doctors to determine the severity of the disease. For instance, in 2024, the American Cancer Society, a US-based professional organization based, reported that 2 million new cancer cases were diagnosed in the country, up from 1.9 million new cases in 2023. Therefore, the increasing incidences of cancer across the globe drive the growth of the cancer and tumor profiling market.

What Is Driving The Cancer Tumor Profiling Market? Growing Incidence Of Stomach Cancer

The growing incidence of stomach cancer is expected to propel the growth of the cancer and tumor profiling market going forward. Stomach cancer refers to the uncontrolled growth and multiplication of malignant cells in the lining of the stomach. while gastrointestinal stromal tumors (GISTs) can occur in the stomach, they are distinct from stomach cancer. When two separate tumors collide and merge into one, patients with GISTs have been found to have an increased risk of developing additional cancers, including small bowel adenocarcinoma. Cancer and tumor profiling provides information regarding the cancer development in stomach and help to provide better treatment. For instance, according to Cancer Research UK, a UK-based independent cancer research organization, the incidence of stomach cancer in the UK is projected to fall by 12% between 2023-2025 and 2038-2040, to 8 cases per 100,000 people on average each year. Therefore, the growing incidence of stomach cancer is driving the growth of the cancer and tumor profiling market.

Who Are The Major Players In The Global Cancer Tumor Profiling Market?

Major companies operating in the cancer tumor profiling market include F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, Genomic Testing Cooperative, OncoDNA, Strata Oncology Inc., Genuity Science, RareCyte Inc., Inivata Limited, Cepheid

What Are The Key Trends Of The Global Cancer Tumor Profiling Market? Increasing Research And Development Activities

The increasing research and development activities have emerged as the key trend gaining popularity in cancer and tumor profiling market. Major companies operating in cancer and tumor profiling sector are focused on research and development activities to meet consumer demand and reinforce their position. For instance, QIAGEN N.V, a German company that develops sample and assay technology for applied testing, pharmaceutical development, molecular diagnostics, and academic research announced the Conformitè Europëenne (CE)-marking and commercialization of therascreen PIK3CA RGQ PCR Kit in Europe as a tool to help identify breast cancer patients with PIK3CA mutations. The therascreen PIK3CA test is a diagnostic assay for the detection of an activating mutation in the phosphatidyl 3-kinase catalytic subunit alpha (PIK3CA) gene, and first to allow testing of both DNA from plasma specimens or FFPE tissue.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Cancer Tumor Profiling Market? Quest Diagnostics Acquired Haystack Oncology

In June 2023, Quest Diagnostics, a US-based medical laboratory company, acquired Haystack Oncology Inc. for $450 million. Through this acquisition, Quest Diagnostics aims to expand access to liquid biopsy technology and increase market share in cancer diagnostics through enhanced research and development capabilities. Haystack Oncology Inc. is a US-based early-stage oncology company that develops solid tumor testing technology to improve outcomes for patients with cancer.

Cancer Tumor Profiling Market Merger And Acquisition: AbbVie Acquires ImmunoGen To Enhance Cancer Therapy Development

In February 2024, AbbVie Inc. acquired a US-based pharmaceutical company, ImmunoGen, Inc., for an undisclosed amount. With this acquisition, AbbVie Inc. aims to strengthen its research and development capabilities, diversify its product offerings, and accelerate growth in key therapeutic areas. ImmunoGen, Inc. is a US-based biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer.

Regional Outlook For The Global Cancer Tumor Profiling Market

North America was the largest region in cancer and tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Cancer Tumor Profiling Market?

The cancer tumor profiling market includes revenues earned by entities by sanger sequencing, pyro sequencing (PyroSeq), chromogenic/ fluorescence in situ hybridization (CISH/FISH) and fragment analysis (FA/Frag. Analysis). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cancer Tumor Profiling Industry?

The cancer tumor profiling market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cancer tumor profiling industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cancer Tumor Profiling Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $14.97 billion
Revenue Forecast In 2034 $25.12 billion
Growth Rate CAGR of 13.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies
3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types
4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications Subsegments: 1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)
2) By Breast Cancer: Hormone Receptor-Positive, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
3) By Colorectal Cancer: Colon Cancer, Rectal Cancer
4) By Prostate Cancer: Localized Prostate Cancer, Advanced Prostate Cancer
5) By Melanoma: Cutaneous Melanoma, Non-Cutaneous Melanoma
6) By Ovarian Cancer: Epithelial Ovarian Cancer, Non-Epithelial Ovarian Cancer 7) By Stomach Cancer: Gastric Adenocarcinoma, Gastrointestinal Stromal Tumors (GISTs) 8) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Neuroendocrine Tumors 9) By Thyroid Cancer: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer 10) By Other Cancer Types: Kidney Cancer, Bladder Cancer, Liver Cancer, Esophageal Cancer
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, Genomic Testing Cooperative, OncoDNA, Strata Oncology Inc., Genuity Science, RareCyte Inc., Inivata Limited, Cepheid
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Cancer Tumor Profiling Market Characteristics

3. Cancer Tumor Profiling Market Trends And Strategies

4. Cancer Tumor Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cancer Tumor Profiling Growth Analysis And Strategic Analysis Framework

5.1. Global Cancer Tumor Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cancer Tumor Profiling Market Growth Rate Analysis

5.4. Global Cancer Tumor Profiling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cancer Tumor Profiling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cancer Tumor Profiling Total Addressable Market (TAM)

6. Cancer Tumor Profiling Market Segmentation

6.1. Global Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Melanoma

Ovarian Cancer

Stomach Cancer

Pancreatic Cancer

Thyroid Cancer

Other Cancer Types

6.2. Global Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Immunohistochemistry (IHC)

In Situ Hybridization (ISH)

Microarray

Other Technologies

6.3. Global Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genomics

Proteomics

Epigenetics

Metabolomics

Other Types

6.4. Global Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Personalized Medicine

Diagnostics

Biomarker Discovery

Prognostics

Research Applications

6.5. Global Cancer Tumor Profiling Market, Sub-Segmentation Of Lung Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)

6.6. Global Cancer Tumor Profiling Market, Sub-Segmentation Of Breast Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hormone Receptor-Positive

Triple-Negative Breast Cancer

HER2-Positive Breast Cancer

6.7. Global Cancer Tumor Profiling Market, Sub-Segmentation Of Colorectal Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Colon Cancer

Rectal Cancer

6.8. Global Cancer Tumor Profiling Market, Sub-Segmentation Of Prostate Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Localized Prostate Cancer

Advanced Prostate Cancer

6.9. Global Cancer Tumor Profiling Market, Sub-Segmentation Of Melanoma, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cutaneous Melanoma

Non-Cutaneous Melanoma

6.10. Global Cancer Tumor Profiling Market, Sub-Segmentation Of Ovarian Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Epithelial Ovarian Cancer

Non-Epithelial Ovarian Cancer

6.11. Global Cancer Tumor Profiling Market, Sub-Segmentation Of Stomach Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gastric Adenocarcinoma

Gastrointestinal Stromal Tumors (GISTs)

6.12. Global Cancer Tumor Profiling Market, Sub-Segmentation Of Pancreatic Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Exocrine Pancreatic Cancer

Neuroendocrine Tumors

6.13. Global Cancer Tumor Profiling Market, Sub-Segmentation Of Thyroid Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Papillary Thyroid Cancer

Follicular Thyroid Cancer

Medullary Thyroid Cancer

6.14. Global Cancer Tumor Profiling Market, Sub-Segmentation Of Other Cancer Types, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Kidney Cancer

Bladder Cancer

Liver Cancer

Esophageal Cancer

7. Cancer Tumor Profiling Market Regional And Country Analysis

7.1. Global Cancer Tumor Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cancer Tumor Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Tumor Profiling Market

8.1. Asia-Pacific Cancer Tumor Profiling Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Tumor Profiling Market

9.1. China Cancer Tumor Profiling Market Overview

9.2. China Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Tumor Profiling Market

10.1. India Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Tumor Profiling Market

11.1. Japan Cancer Tumor Profiling Market Overview

11.2. Japan Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Tumor Profiling Market

12.1. Australia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Tumor Profiling Market

13.1. Indonesia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Tumor Profiling Market

14.1. South Korea Cancer Tumor Profiling Market Overview

14.2. South Korea Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Tumor Profiling Market

15.1. Western Europe Cancer Tumor Profiling Market Overview

15.2. Western Europe Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Tumor Profiling Market

16.1. UK Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Tumor Profiling Market

17.1. Germany Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Tumor Profiling Market

18.1. France Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Tumor Profiling Market

19.1. Italy Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Tumor Profiling Market

20.1. Spain Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Tumor Profiling Market

21.1. Eastern Europe Cancer Tumor Profiling Market Overview

21.2. Eastern Europe Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Tumor Profiling Market

22.1. Russia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Tumor Profiling Market

23.1. North America Cancer Tumor Profiling Market Overview

23.2. North America Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Tumor Profiling Market

24.1. USA Cancer Tumor Profiling Market Overview

24.2. USA Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Tumor Profiling Market

25.1. Canada Cancer Tumor Profiling Market Overview

25.2. Canada Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Tumor Profiling Market

26.1. South America Cancer Tumor Profiling Market Overview

26.2. South America Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Tumor Profiling Market

27.1. Brazil Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Tumor Profiling Market

28.1. Middle East Cancer Tumor Profiling Market Overview

28.2. Middle East Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Tumor Profiling Market

29.1. Africa Cancer Tumor Profiling Market Overview

29.2. Africa Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Tumor Profiling Market Competitive Landscape And Company Profiles

30.1. Cancer Tumor Profiling Market Competitive Landscape

30.2. Cancer Tumor Profiling Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Caris Life Sciences Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Qiagen Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Tumor Profiling Market Other Major And Innovative Companies

31.1. Ribomed Biotechnologies Inc.

31.2. HTG Molecular Diagnostics Inc.

31.3. NanoString Technologies Inc.

31.4. NeoGenomics Laboratories Inc.

31.5. Lucence Health Inc.

31.6. ACT Genomics Co. LTD

31.7. Strand Life Sciences

31.8. IMB Dx Inc.

31.9. Exact Sciences Corporation

31.10. Guardant Health

31.11. Foundation Medicine Inc.

31.12. Agilent Technologies Inc.

31.13. Myriad Genetics Inc.

31.14. Personal Genome Diagnostics Inc.

31.15. Tempus Labs Inc.

32. Global Cancer Tumor Profiling Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Tumor Profiling Market

34. Recent Developments In The Cancer Tumor Profiling Market

35. Cancer Tumor Profiling Market High Potential Countries, Segments and Strategies

35.1 Cancer Tumor Profiling Market In 2029 - Countries Offering Most New Opportunities

35.2 Cancer Tumor Profiling Market In 2029 - Segments Offering Most New Opportunities

35.3 Cancer Tumor Profiling Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Lung Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Breast Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Colorectal Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Prostate Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Melanoma, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Ovarian Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Stomach Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Pancreatic Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Thyroid Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Other Cancer Types, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Global Cancer Tumor Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Global Cancer Tumor Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Asia-Pacific, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Asia-Pacific, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: China, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: China, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: India, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: India, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Japan, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Japan, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Australia, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Australia, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Indonesia, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Indonesia, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: South Korea, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: South Korea, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Western Europe, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Western Europe, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: UK, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: UK, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Germany, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Germany, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: France, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: France, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Italy, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Italy, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Spain, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Spain, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Eastern Europe, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Eastern Europe, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Russia, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Russia, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: North America, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: North America, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: USA, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: USA, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Canada, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Canada, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: South America, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: South America, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Brazil, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Brazil, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Middle East, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Middle East, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Africa, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 84: Africa, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 85: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 86: Caris Life Sciences Financial Performance
  • Table 87: Thermo Fisher Scientific Inc. Financial Performance
  • Table 88: Illumina Inc. Financial Performance
  • Table 89: Qiagen Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Lung Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Breast Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Colorectal Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Prostate Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Melanoma, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Ovarian Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Stomach Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Pancreatic Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Thyroid Cancer, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Cancer Tumor Profiling Market, Sub-Segmentation Of Other Cancer Types, By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Global Cancer Tumor Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Global Cancer Tumor Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Asia-Pacific, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Asia-Pacific, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: China, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: China, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: India, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: India, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Japan, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Japan, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Australia, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Australia, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Indonesia, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Indonesia, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: South Korea, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: South Korea, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Western Europe, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Western Europe, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: UK, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: UK, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Germany, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Germany, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: France, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: France, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Italy, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Italy, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Spain, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Spain, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Eastern Europe, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Eastern Europe, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Russia, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Russia, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: North America, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: North America, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: USA, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: USA, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Canada, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Canada, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: South America, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: South America, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Brazil, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Brazil, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Middle East, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Middle East, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Africa, Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 84: Africa, Cancer Tumor Profiling Market, Segmentation By Process Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 85: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 86: Caris Life Sciences Financial Performance
  • Figure 87: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 88: Illumina Inc. Financial Performance
  • Figure 89: Qiagen Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Explore the latest trends, growth insights, and forecasts in the Global Wearable Fitness Trackers Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Global Wearable Fitness Trackers Market.

Cancer Tumor Profiling Global Market Report 2025 – By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer...

View Report

Cancer Profiling Global Market Report 2025 – By Technology (Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization), By Biomarker Type (Genomic Biomarkers, Pr...

View Report

Cancer Biomarker Global Market Report 2025 – By Biomarkers Type (Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers), By Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioinfo...

View Report

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Li...

View Report

Oncology Biomarkers Global Market Report 2025 – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers), By Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioin...

View Report

Skin Cancer Diagnostics Global Market Report 2025 – By Cancer Type (Basal Cell Carcinoma, Squamous Cell Carcinoma, Malignant Melanoma, Other Cancer Types), By Type (Diagnosis, Therapeutics), By Application (Hospital, Cli...

View Report

Multi Cancer Early Detection Global Market Report 2025 – By Type (Liquid Biopsy, Gene Panel, Laboratory Developed Tests (LDT), Other Types), By Cancer Type (Solid Tumors, Hematological Malignancies), By End-User (Hospita...

View Report

Artificial Intelligence In Cancer Diagnostics Global Market Report 2025 – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor...

View Report

Frequently Asked Questions

Cancer tumor profiling refers to a laboratory test that examines a sample of tumor tissue for specific genes, gene mutations (changes), proteins, or other biomarkers. Tumor profiling can help with treatment planning as well as predicting if cancer will recur or spread to other parts of the body. For further insights on this market, request a sample here

The market major growth driver - Rising Incidences Of Cancer Across Globe. For further insights on this market, request a sample here

The cancer tumor profiling market size has grown rapidly in recent years. It will grow from $13 billion in 2024 to $14.97 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to increasing cancer incidence, growth in precision medicine initiatives and research collaborations, improved cancer diagnostics and early detection methods, availability of a wide range of targeted therapy options, and supportive regulatory frameworks for cancer profiling tests. The cancer tumor profiling market size is expected to see rapid growth in the next few years. It will grow to " $25.12 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to expansion of immunotherapy and immunoprofiling in cancer treatment, development of liquid biopsy and non-invasive tumor profiling methods, adoption of single-cell sequencing for more detailed tumor characterization, expansion of cancer screening and early detection programs, and increasing demand for rare and orphan cancer subtype profiling. Major trends in the forecast period include integration of tumor profiling into routine clinical practice, advances in multi-omics approaches, integration of artificial intelligence (AI) and machine learning in data analysis, personalized medicine and targeted therapy development, and advances in genomics and next-generation sequencing (ngs) technologies. For further insights on this market, request a sample here

The cancer tumor profilingmarket covered in this report is segmented –
1) By Cancer Type: Lung Cancer; Breast Cancer; Colorectal Cancer; Prostate Cancer; Melanoma; Ovarian Cancer; Stomach Cancer; Pancreatic Cancer; Thyroid Cancer; Other Cancer Types
2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Immunohistochemistry (IHC); In Situ Hybridization (ISH); Microarray; Other Technologies
3) By Process Type: Genomics; Proteomics; Epigenetics; Metabolomics; Other Types
4) By Application: Personalized Medicine; Diagnostics; Biomarker Discovery; Prognostics; Research Applications Subsegments:
1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC); Small Cell Lung Cancer (SCLC)
2) By Breast Cancer: Hormone Receptor-Positive; Triple-Negative Breast Cancer; HER2-Positive Breast Cancer
3) By Colorectal Cancer: Colon Cancer; Rectal Cancer
4) By Prostate Cancer: Localized Prostate Cancer; Advanced Prostate Cancer
5) By Melanoma: Cutaneous Melanoma; Non-Cutaneous Melanoma
6) By Ovarian Cancer: Epithelial Ovarian Cancer; Non-Epithelial Ovarian Cancer
7) By Stomach Cancer: Gastric Adenocarcinoma; Gastrointestinal Stromal Tumors (GISTs)
8) By Pancreatic Cancer: Exocrine Pancreatic Cancer; Neuroendocrine Tumors
9) By Thyroid Cancer: Papillary Thyroid Cancer; Follicular Thyroid Cancer; Medullary Thyroid Cancer
10) By Other Cancer Types: Kidney Cancer; Bladder Cancer; Liver Cancer; Esophageal Cancer For further insights on this market, request a sample here

North America was the largest region in cancer and tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the cancer tumor profiling market include F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, Genomic Testing Cooperative, OncoDNA, Strata Oncology Inc., Genuity Science, RareCyte Inc., Inivata Limited, Cepheid . For further insights on this market, request a sample here.

Major trends in this market include Increasing Research And Development Activities. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Cancer Tumor Profiling Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon